Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001641172-25-005602
Filing Date
2025-04-22
Accepted
2025-04-21 19:09:03
Documents
8

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 741550
2 ex5-1.htm EX-5.1 9653
3 ex23-1.htm EX-23.1 2613
4 ex107.htm EX-FILING FEES 22284
5 chart_001.jpg GRAPHIC 202522
6 logo_001.jpg GRAPHIC 9176
7 logo_01.jpg GRAPHIC 4839
8 ex5-1_001.jpg GRAPHIC 14604
  Complete submission text file 0001641172-25-005602.txt   1095862
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-286662 | Film No.: 25854671
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)